LaSalle Street Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

LaSalle Street Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,445	Closed	-$207K	–	91
2016 Q2	$207K	Buy	+1,445	New	+$206K	0.2%	82
2016 Q1	–	Sell	-1,499	Closed	-$208K	–	83
2015 Q4	$208K	Buy	+1,499	New	+$208K	0.21%	79

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

LaSalle Street Capital Management's BIO Position: Q3 2016 in Review

LaSalle Street Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2016, closing a stake of 1,445 shares — an estimated $207K sold.

LaSalle Street Capital Management first reported a position in BIO in Q4 2015 and held it in 2 quarters. The position peaked at $208K in Q4 2015. 241 funds tracked by Wall St. Rank hold BIO as of Q3 2016.

LaSalle Street Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2016 after selling out during the quarter.
LaSalle Street Capital Management sold 1,445 Bio-Rad Laboratories Class A shares in Q3 2016, an estimated $207K.
LaSalle Street Capital Management first reported a position in Bio-Rad Laboratories Class A in Q4 2015 and held it in 2 quarters.
LaSalle Street Capital Management's Bio-Rad Laboratories Class A position peaked at $208K in Q4 2015.
241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2016.

Based on LaSalle Street Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.